Search results for: 'plan pharmaceutical'

Supply chain in any organization is literally its backbone. Cutting across a range of functions, it traverses across the life cycle of a product. Even a slight impediment can affect the entire value chain, run schedules off track, and significantly hamper productivity and efficiency. As companies struggle with visibility and transparency in the tra...

Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

10 Dec 2015  |  Asia Pacific  |  Megatrends

Top 10 Smart Cities of Asia-Pacific by 2025

An Overview of the smart city landscape

Infographics

×

Asia-Pacific is a frontier of growth, development, and activity having quickly embraced disruptive trends in its journey to grow. This ecosystem depicts an eclectic mix of cities. This research service explores the dynamics, plans, and trends in the developments of smart cities in the Asia-Pacific region. It explores how governments, companies, and...

27 Nov 2017  |  North America  |  Market Research

Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021

New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology

Infographics

×

Key Issues Addressed

Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

With a strong resurgence in traffic volumes and shifting customer demands, rail is becoming the favoured choice as cities across the globe seek the most economical and fuel-efficient modes of travel. Western Europe is the largest market, and Germany is expected to require a vast number of regional and commuter transport vehicles in the next 10 ye...

The precision medicine paradigm has found its early roots in genetic profiling, as genomics have proven their potential in helping clinicians decide on the right treatment for the right patient at the right time. Not far behind is medical imaging, which is rapidly developing its own, image-based approaches to tailoring decisions and care pathways t...

The research service offers a macro-to-micro analysis of the global urbanization Mega Trend and identifies the business opportunities in cities of the future. The research focuses on the flow of urban populations and patterns in Mega Cities, Mega Regions, and Mega Corridors that will evolve with planned developments in investment, infrastructure, a...

As Europe battles unequal growth and environmental, economic, social, and political challenges, Britain has chosen to fight its challenges alone. This study puts forth a hypothetical timeline to the events that might unfold in the next five years and examines the potential trade models that may come to reality between Britain and the European Union...